Honasa Consumer, the parent company of Mamaearth, has acquired a 58% stake in Fluence Pharma, marking its entry into the fast-growing nutraceuticals segment and expanding its presence beyond traditional beauty and personal care categories.
The company said the acquisition will enable it to tap into India’s nutraceuticals market, which is currently valued at over Rs 16,000 crore, while strengthening its focus on science-backed “inside-out” beauty solutions.
As part of the expansion, Honasa has established a dedicated subsidiary, Honasa Health, which will build and scale a business-to-consumer nutrition portfolio by combining Fluence Pharma’s patented clinical science with Honasa’s brand-building, consumer insights and digital distribution capabilities.
Founded by Amit Bhusari and dermatologist Dr. Rajendra Singh Rajput, Fluence Pharma is known for its patented Cyclical Nutrition Therapy (CNT) platform and offers over-the-counter nutritional solutions for hair and skin concerns. The company has built a network of more than 3,000 practicing dermatologists and reported approximately Rs 40 crore in revenue with over 20% EBITDA margin in FY26.
Honasa said the new venture will be led by Dheeraj Nagpal, CEO of Honasa Health. Nagpal previously co-founded nutraceutical brand Zingavita and has also held leadership roles at Zomato and American Express.
Commenting on the acquisition, Varun Alagh, Co-founder and CEO, Honasa Consumer Limited, said, “The beauty and personal care landscape is entering a new era where consumers are increasingly seeking holistic, inside-out solutions that address beauty concerns at their root. While the last decade was shaped by topical actives, we believe the next decade will be defined by the powerful convergence of science backed skin and hair care, and nutraceuticals.”
He also added, “Fluence has built a strong scientific foundation through its patented Cyclical Nutrition Therapy, setting a benchmark for clinically validated efficacy. We are excited to build on this foundation and scale it through Honasa Health, creating a consumer-first nutraceuticals franchise that complements our science-led beauty portfolio. This marks an important step in our vision of building a future-ready House of Brands and a more resilient, diversified growth engine.”
Amit Bhusari, CEO & Co-founder, Fluence Pharma, added, “For the past ten years, we have focused rigorously on grounding our portfolio in science and earning the trust of the medical fraternity. To unlock the true potential of our proprietary science, however, we needed a partner who could take these clinical solutions to a wider consumer base. Honasa Consumer brings the perfect opportunity and infrastructure for us. Their unparalleled digital-first capabilities, data-driven consumer insights, and proven track record of scaling young brands will allow us to strengthen our distribution and solve consumer problems across India.”
